SCHEMBL18156907

SCHEMBL18156907

CC(O)(c1ccc(NC(=O)Cc2cccc(S(=O)(=O)NC3CC3)c2)cc1)C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RORC P51449 7/20 0.47
CYP2D6 P10635 2/20 0.47
MAPT P10636 4/20 0.44
LMNA P02545 4/20 0.44
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
TP53 P04637 3/20 0.43
PDK1 Q15118 2/20 0.43
PDK2 Q15119 2/20 0.43
PDK3 Q15120 2/20 0.43
PDK4 Q16654 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
GAA P10253 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
IDH2 P48735 1/20 0.42
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18156917 0.96 MAPT (0.47) RORCCYP2D6MAPTLMNAALDH1A1
SCHEMBL18151519 0.90 RORC (0.54) RORCCYP2D6MAPTLMNAALDH1A1
SCHEMBL18151510 0.88 RORC (0.56) RORCCYP2D6MAPTMEN1KMT2A
SCHEMBL18156925 0.88 PDK1 (0.45) RORCCYP2D6LMNAALDH1A1MEN1
SCHEMBL18156926 0.87 PDK1 (0.44) RORCCYP2D6MAPTLMNAALDH1A1
SCHEMBL18156924 0.87 LMNA (0.43) RORCCYP2D6MAPTLMNAALDH1A1
SCHEMBL18156923 0.87 LMNA (0.43) RORCCYP2D6MAPTLMNAALDH1A1
SCHEMBL18156949 0.87 PDK1 (0.46) RORCMAPTLMNAALDH1A1MEN1
SCHEMBL18151611 0.87 RORC (0.45) RORCCYP2D6MAPTLMNAALDH1A1
SCHEMBL18156912 0.87 RORC (0.49) RORCCYP2D6MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738600-B2 ROR gamma (RORγ) modulators LEAD PHARMA CEL MODELS IP B.V. (NL) 2017-08-22 US disclosed
US-20160304448-A1 ROR GAMMA (RORy) MODULATORS LEAD PHARMA CEL MODELS IP B.V. (NL) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304448-A1 ROR GAMMA (RORy) MODULATORS RORC, RORA, RORB RORC 1/4885CYP2D6 645/4885MAPT 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.